In his State of the Union address on Tuesday, President Joe Biden reiterated his desire to drive down the price of pharmaceuticals in the U.S., a move that was thwarted in January after his massive spending package Build Back Better plan didn’t make it through the Senate.
Source: Drug Industry Daily